Progenics Pharmaceuticals Inc.

(PGNX) Trade

By |

Profile

Progenics Pharmaceuticals Inc is a biopharmaceutical company that develops innovative medicines and other technologies to identify, target and treat cancer. Its pipeline drugs include AZEDRA and 1095; 1404 and PyL; and imaging analysis tools.

Contact Information

Website: www.progenics.com
Email: investor.relations@progenics.com
Main Phone: +1 646 975-2500
Address: One World Trade Center, 47th Floor
Address 2: Suite J
State: NY
City / Town: New York
Country: USA
Postal Code: 10007

Issuer Information

Exchange: NGS
CEO: Mark R. Baker
Employees: 64
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 8.26 $ -0.13 (-1.55%)
Last Price 8.26 Change $ -0.13 Change % -1.55 Tick N/A
Bid 8.20 Bid Size 100.00 Ask 8.58 Ask Size 500.00
Open 8.35 High 8.48 Low 8.23 Prev Close 8.39
Last Trade Volume 819,577 52 Wk Hi 9.12 52 Wk Low 4.60
Market Cap 608.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 73,718,684.00 EPS (TTM) -0.69 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Mark R. Baker 1,000
Last 10 Sell Shares
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
Kevin Kotler 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 12 12 12 12
Mean Target Price Estimate 13.5 13.5 13.5 13.5
Standard Deviation 2.12 2.12 2.12 2.12
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1